28.06.2014 Views

Autologous Bone Marrow Transplantation - Blog Science Connections

Autologous Bone Marrow Transplantation - Blog Science Connections

Autologous Bone Marrow Transplantation - Blog Science Connections

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

56 ABMTIn CR2<br />

RESULTS OF VARIOUS TREATMENT MODALITIES IN<br />

ACUTE LEUKEMIA AFTER FIRST<br />

COMPLETE REMISSION<br />

After CR1, remission is induced in 40-60% of patients. The long-term<br />

DFS rate is below 10%. We define DFS as a remission lasting longer than 12<br />

months. Inversion, defined as a duration of CR2 longer than that of CR1 or a<br />

duration of third complete remission longer than that of CR2, also occurred in<br />

less than 10% of patients. Our results at The University of Texas M. D.<br />

Anderson Hospital and Tumor Institute at Houston are similar. Remission<br />

reinduction in acute myelogenous leukemia (AML) is 50% and in acute<br />

lymphocytic leukemia 75%. Our continuous complete remission rate is less<br />

than 10%.<br />

Figure 1 diagrams the results of other treatments. Patients treated with<br />

high-dose cytoreductive therapy and allogeneic or isogeneic bone marrow<br />

transplantation have a 35-40% chance of long-term DFS (3). The inversion<br />

rate is identical to the long-term DFS rate. In the patient group treated with<br />

4-hydroperoxycyclophosphamide (4-HC)-purged autologous marrow reported<br />

by Johns Hopkins Hospital, the long-term DFS rate is 30% (5). However, the<br />

inversion rate in that population is 23%. Ramsay has reported that 6 out of 22<br />

patients treated in CR2 or a subsequent remission with monoclonal antibodypurged<br />

marrow plus cyclophosphamide plus total body irradiation (TBI) have<br />

achieved long-term DFS status (6). The inversion rate in this study is 27%.<br />

The updated status of the control group for our forthcoming study,<br />

patients treated in second and subsequent remissions with unpurged marrow<br />

plus CBV, is depicted in Figure 2. Only 4 of the 22 patients had a remission of<br />

ALLOGENEIC BMT: 30-10%.<br />

'INVERSION RATE IDENTICAL<br />

SYNGENEIC BMT:<br />

PURGED - AUTO BMT: INVERSION RATE 23%<br />

Î<br />

UNPURGED AUTO BMT: 1«<br />

NORMAL DOSE CHEMOTHERAPY: 10%<br />

Figure 1. Continuous complete remissions after various treatment modalities in second<br />

and third remissions of acute leukemia. BMT = bone marrow transplantation; auto =<br />

autologous.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!